Race for a Remedy: The Science and Scientists behind the Next Life-Saving Cancer Medicine

How does a mere molecule-a chemical structure-become a drug? And how do we know that it works safely? In a one-trillion-dollar pharmaceutical industry with high-stakes profits and perils, battles are raging every day to successfully bring a molecule to its birth: an FDA-approved medicine. In Race for a Remedy, Makhdum Ahmed, MD, an internationally renowned expert in cancer treatment and drug development, takes readers behind the scenes of the fascinating and intense world of cancer drug development.

Whether it's a small molecule, a versatile monoclonal antibody, or the fancy, poster child of cutting-edge cell therapy, modern drugs are built upon a centuries-old solid foundation set by the pioneers of medicine and immunology. This revealing book also explores the struggles of current-day pharmaceutical and biotech industries to overtake competitors and make sure their molecule reaches the finish line first. For leading cancer drug developers, that means achieving the ultimate goal: creating the next life-saving cancer medicine.

Readers will also find answers to common questions on drugs, such as:

  • How long does it usually take for a drug to come to market?
  • When can we expect a cure for cancers like leukemia and lymphoma?
  • Are experimental medicines unsafe?
  • Given my illness (or that of my loved one), should I join a clinical trial, and what are the odds it will help?

A leading medical expert on the front lines of drug creation, Dr. Ahmed offers basic pharmacological insights, revolutionary science, and the gripping arc of new drug development. Race for a Remedy will change the way readers think about medicine.

"1145949328"
Race for a Remedy: The Science and Scientists behind the Next Life-Saving Cancer Medicine

How does a mere molecule-a chemical structure-become a drug? And how do we know that it works safely? In a one-trillion-dollar pharmaceutical industry with high-stakes profits and perils, battles are raging every day to successfully bring a molecule to its birth: an FDA-approved medicine. In Race for a Remedy, Makhdum Ahmed, MD, an internationally renowned expert in cancer treatment and drug development, takes readers behind the scenes of the fascinating and intense world of cancer drug development.

Whether it's a small molecule, a versatile monoclonal antibody, or the fancy, poster child of cutting-edge cell therapy, modern drugs are built upon a centuries-old solid foundation set by the pioneers of medicine and immunology. This revealing book also explores the struggles of current-day pharmaceutical and biotech industries to overtake competitors and make sure their molecule reaches the finish line first. For leading cancer drug developers, that means achieving the ultimate goal: creating the next life-saving cancer medicine.

Readers will also find answers to common questions on drugs, such as:

  • How long does it usually take for a drug to come to market?
  • When can we expect a cure for cancers like leukemia and lymphoma?
  • Are experimental medicines unsafe?
  • Given my illness (or that of my loved one), should I join a clinical trial, and what are the odds it will help?

A leading medical expert on the front lines of drug creation, Dr. Ahmed offers basic pharmacological insights, revolutionary science, and the gripping arc of new drug development. Race for a Remedy will change the way readers think about medicine.

34.99 Pre Order
Race for a Remedy: The Science and Scientists behind the Next Life-Saving Cancer Medicine

Race for a Remedy: The Science and Scientists behind the Next Life-Saving Cancer Medicine

by Makhdum Ahmed M.D.

Narrated by Pat Grimes

Unabridged

Race for a Remedy: The Science and Scientists behind the Next Life-Saving Cancer Medicine

Race for a Remedy: The Science and Scientists behind the Next Life-Saving Cancer Medicine

by Makhdum Ahmed M.D.

Narrated by Pat Grimes

Unabridged

Audiobook (Digital)

$34.99
FREE With a B&N Audiobooks Subscription | Cancel Anytime
$0.00

Free with a B&N Audiobooks Subscription | Cancel Anytime

START FREE TRIAL

Already Subscribed? 

Sign in to Your BN.com Account

Available for Pre-Order. This item will be released on September 3, 2024

Listen on the free Barnes & Noble NOOK app


Related collections and offers

FREE

with a B&N Audiobooks Subscription

Or Pay $34.99

Overview

How does a mere molecule-a chemical structure-become a drug? And how do we know that it works safely? In a one-trillion-dollar pharmaceutical industry with high-stakes profits and perils, battles are raging every day to successfully bring a molecule to its birth: an FDA-approved medicine. In Race for a Remedy, Makhdum Ahmed, MD, an internationally renowned expert in cancer treatment and drug development, takes readers behind the scenes of the fascinating and intense world of cancer drug development.

Whether it's a small molecule, a versatile monoclonal antibody, or the fancy, poster child of cutting-edge cell therapy, modern drugs are built upon a centuries-old solid foundation set by the pioneers of medicine and immunology. This revealing book also explores the struggles of current-day pharmaceutical and biotech industries to overtake competitors and make sure their molecule reaches the finish line first. For leading cancer drug developers, that means achieving the ultimate goal: creating the next life-saving cancer medicine.

Readers will also find answers to common questions on drugs, such as:

  • How long does it usually take for a drug to come to market?
  • When can we expect a cure for cancers like leukemia and lymphoma?
  • Are experimental medicines unsafe?
  • Given my illness (or that of my loved one), should I join a clinical trial, and what are the odds it will help?

A leading medical expert on the front lines of drug creation, Dr. Ahmed offers basic pharmacological insights, revolutionary science, and the gripping arc of new drug development. Race for a Remedy will change the way readers think about medicine.


Product Details

BN ID: 2940192249765
Publisher: Dreamscape Media
Publication date: 09/03/2024
Edition description: Unabridged
From the B&N Reads Blog

Customer Reviews